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Macrophage stimulating protein (MSP) exists in blood as
inactive pro-MSP. Cleavage yields active MSP, the ligand
for a membrane receptor (RON) that is expressed on
keratinocytes as well as macrophages. Because both cells
have roles in tissue injury, we looked for active MSP
and expressed RON in wounds. Concentration of pro-
MSP F MSP in wound exudates was in the range
for optimal activity. Western blot showed that MSP
comprised about half the total, in contrast to less than
10% of the total in blood plasma. The presence of MSP
was attributed to an exudate pro-MSP convertase that
had an inhibitor profile consistent with a trypsin-like
serine protease. Exudate evoked morphologic changes in
Macrophage stimulating protein (MSP) was originallyidentified as a mammalian serum protein that causedshape changes in murine peritoneal resident macro-phages and made them responsive to chemo-attractants (Leonard and Skeel, 1976, 1978). MSP
also acts directly as a chemoattractant for resident macrophages (Skeel
and Leonard, 1994), stimulates macrophage ingestion of C3 bi-coated
erythrocytes via the CR3 integrin receptor (Skeel et al, 1991), inhibits
expression of inducible nitric oxide synthase mRNA in endotoxin or
cytokine-stimulated macrophages (Wang et al, 1994a), and stimulates
proliferation or motility in selected epithelial cell lines (Wang et al,
1996a, b).
Purification and cloning MSP showed that it belongs to a family of
proteins that have evolved from an ancient serine protease precursor
(Donate et al, 1994) and that have retained a highly conserved triple
disulfide loop structure (kringle). Typical family members, including
prothrombin and plasminogen, circulate in the blood as serine protease
zymogens, which are activated by proteolytic cleavage to participate
in coagulation or fibrinolysis. Amino acid substitutions in the serine
protease catalytic triad have resulted in loss of enzymatic activity of
Manuscript received February 14, 1998; revised April 17, 1998; accepted for
publication May 22, 1998.
Reprint requests to: Dr. Lillian Nanney, Department of Plastic Surgery,
Vanderbilt U School Med, S-2221, Med Ctr N, Nashville, TN 37232–2631.
Abbreviations: MSP, macrophage stimulating protein; RON, membrane
receptor for MSP.
1Current address: Division of Pulmonary Medicine, Wayne State University,
VA Medical Center, B-4365, 4646 John Rd, Detroit, MI 48201.
0022-202X/98/$10.50 · Copyright © 1998 by The Society for Investigative Dermatology, Inc.
573
macrophages in vitro like that of MSP. Removal of this
activity by an anti-MSP column shows that exudate
stimulation of macrophages is due to MSP. RON was
infrequently detected in normal skin. RON protein was
markedly upregulated in burn wound epidermis and
accessory structures, in proliferating cells or differentiated
cells, or both. RON was also detected on macrophages
and capillaries. Tissue injury leads to cleavage of pro-
MSP to MSP, which has potential to act on keratinocytes,
macrophages, and capillaries, all components of the
wound healing response. Key words: enzyme activation/
keratinocytes/receptor tyrosine kinase/wound. J Invest Dermatol
111:573–581, 1998
two family members, MSP and hepatocyte growth factor/scatter factor
(Matsumoto and Nakamura, 1992). Both proteins have retained the
activation mechanism, however, in that they are secreted as biologically
inactive single chain precursors, which become active after proteolytic
cleavage at a single site to yield disulfide-linked αβ-chain heterodimers.
It is reasonable to speculate that the common functional denominator
for this kringle protein family is host defense response to wounding:
blood coagulation, fibrinolysis, and stimulation of cells for debridement
and repair.
In contrast to the coagulation and fibrinolytic kringle proteins,
relatively little is known about the identity and locus of pro-MSP
convertases, the enzymes that cleave pro-MSP to biologically active
mature MSP. If MSP has a role in host response to wounding, pro-
MSP would be expected to diffuse with other serum proteins into the
wound exudate where a convertase would cleave it to MSP. Although
several pure enzymes of the coagulation cascade, including kallikrein,
factor XIIa, and factor XIa, cleave and activate pro-MSP (Wang et al,
1994), this does not occur when blood clots (Wang et al, 1996b),
indicating that pro-MSP is not a preferred substrate for these enzymes.
We recently showed that murine peritoneal macrophages have a cell
surface pro-MSP convertase activity (Wang et al, 1996b). This in vitro
finding suggests that resident dermal macrophages, potential target
cells, might also have the capacity to generate the active ligand from
the inactive precursor. This study is the first attempt to detect pro-
MSP conversion in vivo, by testing for the presence of mature MSP as
well as pro-MSP convertase activity in wound fluid.
The other part of our study relates to RON, the MSP receptor.
The RON gene was cloned from a human foreskin keratinocyte
cDNA library (Ronsin et al, 1993). RON belongs to a family of
receptor protein tyrosine kinases that includes Met (Park et al, 1987),
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Figure 1. Detection of mature MSP in wound fluids. Immunoprecipitation
with immobilized monoclonal anti-MSP and western blot with polyclonal
antibody to MSP α-chain. Lane 1, medium control; lane 2, recombinant mature
MSP; lane 3, recombinant pro-MSP; lane 4, patient BC, blood plasma; lane 5,
patient BC, wound fluid, day of surgery; lane 6, patient BC, wound fluid, first
postoperative day; lane 7, patient SK, blood plasma; lane 8, patient SK, wound
fluid, first postoperative day. An α-chain band characteristic of mature MSP is
present in lanes 2, 5, 6, and 8.
Table I. Presence of mature MSP in surgical and burn wound
fluids
aA280
a [pro – MSP 1 MSP] MSP, % of totalc
(nM)b
Breast reduction fluid 46 6 9 5.7 6 0.6 56 6 2
sampled at 24 h
(n 5 8)
Burn wound fluid 53 6 14 6.1 6 1.4 56 6 7
sampled in first 24 h
(n 5 5)
Normal blood plasma 65 6 5 4.9 6 0.7 8 6 5
(n 5 4)
aValues of fluids diluted 1:50 in 0.15 M NaCl were multiplied by the dilution factor
to give the numbers shown.
bDetermined by a sandwich enzyme-linked immunosorbent assay that detects both
pro-MSP and MSP.
cFluids were immunoprecipitated with monoclonal anti-MSP covalently bound to
Sepharose-4B. After SDS-PAGE under reducing conditions, proteins were transferred to
Immobilon and immunoblotted with antibody to MSP α-chain, which detects both
MSP and pro-MSP. Relative intensities of the pro-MSP and MSP bands were
determined by densitometry of negative transparencies.
the receptor for hepatocyte growth factor/scatter factor (Bottaro et al,
1991), a ligand with 45% sequence similarity to MSP (Yoshimura et al,
1993). Studies of cells transfected with the RON cDNA showed that
MSP is a ligand for RON, because it bound specifically and saturably
to these cells and caused receptor phosphorylation (Wang et al, 1994c).
Cloning of RON from a keratinocyte cDNA library suggested that
MSP might be a modulator of keratinocyte activites. This led to two
reports showing that MSP induced the migration and proliferation of
a number of murine keratinocyte cell lines (Wang et al, 1996a) and
migration of human keratinocyte cell lines (Wang et al, 1996b). The
capacity of MSP to stimulate both macrophages and keratinocytes
suggested that this protein might play a role in wound repair, a
possibility evaluated in this study.
MATERIALS AND METHODS
Reagents Recombinant human pro-MSP and MSP were from Toyobo
(Osaka, Japan). Mouse monoclonal antibody to the extracellular domain of
RON was a gift from Dr. Felix Montero-Julian (Immunotech, Marseille,
France). As determined by flow cytometry, the antibody binds to Madin-Darby
canine kidney epithelial cells transfected with RON cDNA. There is no
detectable binding to nontransfected cells (Danilkovitch and Leondard, unpub-
lished observations). Monoclonal anti-MSP was as described (Skeel et al, 1991).
Rabbit antibodies to MSP and to MSP α-chain were as described (Wang et al,
1993). Monoclonal antibody AM-3K, which is specific for human macrophages
(Zeng et al, 1996), was a gift from Motohiro Takeya (Kumamoto University
Medical School, Kumamoto, Japan). Secondary antibodies for immunohisto-
chemistry were from Jackson ImmunoResearch (West Grove, PA). Leupeptin
Figure 2. MSP in wound fluids collected from three patients at different
times after reduction mammoplasty. Fluids were immunoprecipitated and
analyzed as described in Table I.
and aprotinin were from Boehringer (Indianapolis, IN). Human serum kallikrein,
C-1 esterase inhibitor, α-2-macroglobulin, and α-1-antichymotrypsin were
from Athens Research and Technology (Athens, GA). Coagulation factors XIa
and XIIa were from Enzyme Research Laboratories (South Bend, IN). Protease-
free bovine serum albumin, 4-(1-aminoethyl)-benzenesulfonylfluoride and Phe-
Pro-Arg-CH2 CL were from Calbiochem (La Jolla, CA). Alkaline phosphatase
conjugated anti-rabbit IgG and soybean trypsin inhibitor were from Sigma
(Cleveland, OH). Peroxidase conjugated anti-rabbit IgG was from Bio-Rad
(Richmond, CA).
Sample collection Human partial thickness or edges of full thickness burn
samples (n 5 19) were harvested from various body locations in patients
undergoing routine burn excision and autografting procedures at the Vanderbilt
University Burn Center. Normal skin samples (n 5 6) were collected from
various body regions of patients undergoing elective surgery. Tissue samples
were obtained in accordance with procedures approved by the Institutional
Review Board. Cutaneous specimens were either frozen, sectioned, and
immunostained or were fixed in 4% paraformaldehyde, embedded in paraffin,
sectioned, and immunostained. Venous blood was drawn into syringes containing
ethylenediamine tetraacetic acid (EDTA), aprotinin, and leupeptin, making final
concentrations µ10 mM, 6 µM, and 85 µM, respectively. Exudates were
collected from human burn wound blisters and also from breast reduction
surgical drains. Samples of the latter were obtained by syringe in 1–2 ml
volumes at various times after surgery.
Cells Peritoneal resident macrophages were obtained from C3H/HeN mice
by lavage with RPMI 1640 medium (Skeel et al, 1991). Cells were washed
once in RPMI 1640 and were then resuspended in Dulbecco’s modified Eagle
medium (DMEM) at a concentration of 5 3 105 cells per ml. The cell
suspension was distributed in 0.5 ml aliquots into wells of a 48 well tissue
culture plate and incubated with or without stimulating agents at 37°C in a
humidified incubator containing 5% CO2 in air.
Labeling of human pro-MSP with 125I Fifteen micrograms of pure
recombinant human pro-MSP in 30 µl of 0.1 M borate buffer, pH 8.5, were
added to 250 µCi of Bolton-Hunter reagent (Bolton and Hunter, 1973) and
equilibrated on ice for 150 min. The reaction was terminated by addition of
300 µl of borate buffer containing 0.5 M glycine. After 10 min on ice the
reaction mixture was applied to an Excellulose GF-5 desalting column (Pierce,
Rockford, IL) that had been equilibrated with phosphate-buffered saline
containing 0.25% gelatin. The iodinated protein was eluted with 1 ml of
phosphate-buffered saline-gelatin buffer, and counted in gamma-counter
(Gamma 5500, Beckman). The specific activity of the labeled pro-MSP was
µ400 Ci per mmol.
Sandwich enzyme-linked immunosorbent assay for pro-MSP and
MSP The assay utilized antibodies developed in the authors’ laboratory (Skeel
et al, 1991; Wang et al, 1993). The capture antibody was murine IgG monoclonal
anti-MSP, lot 2S (0.1 µg per assay well); the detection antibody was polyclonal
rabbit IgG anti-MSP. Details of the assay have been described (Wang et al,
1993). Dose–response curves for purified human plasma MSP, recombinant
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Figure 3. Pro-MSP convertase activity is detected in wound fluids, but
not in normal human serum. 125I-pro-MSP was incubated for 1 h at 37°C
with wound fluids or undiluted sera. Samples were analyzed by radioautography
after SDS-PAGE under reducing conditions. Lanes 1–3, fluids from reduction
mammoplasty drains (1, 2) or burn wound (3); lanes 4–6, sera from three
normal human subjects; lane 7, medium control (1 mg bovine serum albumin
per ml in 20 mM, pH 7.4 phosphate buffer). The three wound fluids cleaved
pro-MSP, as shown by a diminution in the intensity of the pro-MSP line, and
the appearance of lines corresponding to the α- and β-chains of mature MSP.
pro-MSP, and recombinant MSP are comparable (Leonard and Skeel, unpub-
lished data).
Immunoprecipitation and western blot of human plasma and wound
fluids Monoclonal IgG anti-MSP was covalently linked to Sepharose-4B.
One milliliter of a 1:2 dilution of plasma or wound fluid was equilibrated with
30 µl of settled gel on a rocker at 4°C for 2 h. After centrifugation, the
supernatant was discarded and the gel was washed three times. It was then
mixed with 30 µl of 2 3 sample buffer containing 2-mercaptoethanol and
placed in a boiling water bath for 10 min. Twenty microliter volumes were
added to wells of an 8% polyacrylamide gel in a BioRad Mini-Protean II
chamber, and proteins were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). After electrophoresis, the gel was placed in a
BioRad TransBlot cell for transfer of proteins to Immobilon P. After transfer,
the membrane was blocked with a solution of 5% dried milk, rinsed, and
equilibrated overnight with polyclonal rabbit antibody to the α-chain of MSP.
The last step antibody was peroxidase conjugated goat anti-rabbit IgG; protein
bands were detected after addition of 4-chloro-1-naphthol substrate and H2O2.
The membrane was photographed, and the negative was photographed again
to make a positive transparency in which the protein bands appeared as dark
lines. An estimate of the relative amounts of pro-MSP and MSP was made by
densitometry of the two bands, using an LKB densitometer.
Pro-MSP convertase activity of serum or wound fluids The assay was
based on cleavage of labeled pro-MSP and detection of free MSP α-chain by
radioautography after SDS-PAGE under reducing conditions. 125I-pro-MSP
was added to human serum or wound fluids and incubated at 37°C for
different times. Samples were then mixed with sample buffer containing 2-
mercaptoethanol. After SDS-PAGE as described above, the gel was dried and
placed in an intensifying screen cassette with X-ray film (XAR-5; Eastman
Kodak, Rochester, NY). The film was developed after 1–4 d at –80°C.
MSP activity of wound fluids The assay was based on the capacity of MSP
to induce shape change of murine resident peritoneal macrophages in tissue
culture wells. Cells were prepared as described above. They were then incubated
for 1–2 h with DMEM alone, dilutions of wound fluid in DMEM, and MSP
as a positive control. Cells were then fixed and photographed. After we found
that wound fluids had shape change activity, wound fluids were passed down
Sepharose columns with either anti-MSP or a control IgG; eluates were tested
for shape change activity.
Localization of immunoreactive RON receptor Paraffin sections were
dewaxed and microwaved in citrate buffer (Biogenex, San Ramon, CA) in
accordance with antigen retrieval techniques. For both frozen sections and
paraffin-embedded sections, endogenous peroxidase activity was quenched for
20 min in a 3% H2O2/methanol solution. All sections were then equilibrated
in normal 10% porcine serum for 20 min and in primary anti-serum (ID-2
Ron anti-serum) (1:2000) for 18 h in a humidified chamber at 4°C. Serial
sections were incubated in irrelevant anti-sera to distinguish between possible
brown background and specific immunoprecipitates. Tissues were rinsed in
phosphate-buffered saline for 10 min and equilibrated with reagents in a mouse
peroxidase Vectastain ABC kit (Burlingame, CA). Immunoreactive sites were
visualized with 3,3-diaminobenzidine as the chromagen (Biogenex, San Ramon,
CA). Sections were counterstained in hematoxylin and rinsed in water,
dehydrated, coverslipped, and photographed with an Olympus AH Vanox light
microscope.
Figure 4. Time course of 125I-pro-MSP cleavage by wound fluids.
Experimental conditions were as described for Fig 3, except for different
incubation times, shown in minutes.
Localization by immunofluorescence To confirm the presence of the
RON receptor in a macrophage population in normal and burned human skin,
double immunolabeling studies were undertaken. After an antigen retrieval
treatment, sections were equilibrated in anti-RON antibody (1:400 dilution)
for 18 h. Sections were rinsed and equilibrated in biotinylated goat anti-mouse
IgG (1:1000) for 1 h and fluoroscein isothiocyanate-conjugated streptavidin
(1:1000) for 1 h. Sections were then rinsed, blocked with 5% goat serum, and
macrophages were selectively labeled as follows: sections were equilibrated for
3 h in a 1:1000 dilution of a murine monoclonal macrophage specific antibody
(AM-3K), followed by Cy3 conjugated donkey anti-mouse IgG (1:1000 for 1 h).
An additional RON receptor anti-serum was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA), to confirm RON receptor distribution in
normal and burned human skin. In these experiments, sections were equilibrated
for 18 h in the Santa Cruz polyclonal anti-RON receptor serum (1:50) and
reacted with Cy3-goat anti-rabbit IgG (1:1000 for 1 h). Sections were blocked
in 5% goat serum, followed by equilibration in monoclonal AM-3K antibody
for 3 h, followed by sequential equilibration in biotinylated donkey anti-mouse
IgG (1:1000 for 1 h) and fluoroscein isothiocyanate conjugated streptavidin
(1:1000 for 1 h). Unless otherwise noted, all reagents used for immunofluorescent
staining were purchased from Jackson ImmunoResearch. Coverslips were
mounted on slides with Vectashield (Burlingame, CA). Images were viewed on
a Zeiss Axioplan II Microscope, captured using Image ProPlus Software,
formatted for presentation with Adobe Photoshop and printed on a TekTRONic
dye-sublimation printer.
Localization by in situ hybridization Deparaffinized sections were acid
treated to denature RNA at 25°C for 15 min in 0.2 M HCl, followed by
7.5 min of proteinase K treatment 20 µg per ml in 50 mM Tris pH 7.5, 5 mM
EDTA (Sigma, St. Louis, MO) to permeabilize the cells. Sections were postfixed
for 15 min in 4% paraformaldehyde. Samples were briefly acetylated and air
dried. The RON receptor probe was generated by subcloning a BamH1-
Sal1400 bp fragment into a pB/bluescript SK vector (Stratagene, La Jolla, CA).
The plasmid was linearized by BamH1 or Sal1 for anti-sense or sense riboprobe
labeling with T7 or T3 RNA polymerase (Amersham, Arlington Heights, IL)
and 35S-UTP. Hybridization was performed overnight at 50°C and for 4 h at
42°C with 2 3 sodium citrate/chloride buffer/50% formamide for humid-
ification using 200 µl of hybridization mixture to treat the slides at a final probe
concentration of 2 3 104 cpm per µl. The hybridization mixture contained
300 mM NaCl, 10 mM Tris HCl pH 7.4, 10 mM NaH2PO4 pH 6.8,
5 mM EDTA pH 8.0, 0.2% Ficoll 400, 0.2% polyvinyl pyrrolidone, 50 mM
dithiothreitol, 10% Dextran sulfate, 50% deionized formamide, and 10 µg yeast
tRNA per ml. After hybridization, sections were washed in 2 3 sodium citrate/
chloride buffer, 20 mM β-mercaptoethanol at 50°C for 30 min. After two
washes with 4 3 sodium citrate/chloride buffer, 50% formamide, 20 mM β-
mercaptoethanol at 55°C for 30 min each, slides were washed in a buffer
containing 4 3 sodium citrate/chloride buffer, 20 mM TrisHCl pH 7.5, 2 mM
EDTA pH 8.0 at 37°C for 10 min each. Slides were digested with Rnase A
(20 µg per ml) in this same buffer for 30 min. This wash procedure was then
repeated. Slides were rinsed in water, air dried, dipped in Kodak NTB2
Emulsion, exposed for 3 d, and developed with D-19.
RESULTS
Detection of pro-MSP and MSP in wound fluids Using an
enzyme-linked immunosorbent assay that detects both pro-MSP and
MSP, we measured the concentration of [pro-MSP 1 MSP] in fluids
collected from burn wounds and from surgical drains placed after
reduction mammoplasty. As shown in Table I, the concentration was
comparable with that of normal human blood plasma. This was the
expected result, inasmuch as the A280 shows that the fluids are exudates,
with protein concentrations similar to that of blood plasma.
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Figure 5. Effect of different protease inhibitors on wound fluid pro-
MSP convertase activity. Wound fluid from a breast reduction patient was
incubated at 37°C for 20 min with protease inhibitors. 125I-pro-MSP was then
added, and after 3 h solutions were analyzed for pro-MSP cleavage. Lane 1, 4-
(2-aminoethyl)benzesulfonylfluoride, 1 mM; lane 2, aprotinin, 50 µg per ml;
lane 3, leupeptin, 50 µg per ml; lane 4, soybean trypsin inhibitor, 50 µg per
ml; lane 5, Phe-Pro-Arg-chloromethylketone, 10 µM; lane 6, EDTA, 10 mM;
lane 7, α1-antichymotrypsin, 400 µM; lane 8, α2-macroglobulin, 0.3 µM; lane
9, C1-inhbitor, 50 µg per ml; lane 10, wound fluid without inhibitor; lane 11,
medium control (cf. Fig 3, lane 7).
Biologically inactive pro-MSP is the predominant form in normal
human circulating blood. Cleavage of pro-MSP at a single site creates
active MSP, a disulfide-linked αβ-chain heterodimer. Pro-MSP is
readily distinguished from MSP by SDS-PAGE under reducing condi-
tions and western blotting with a polyclonal antibody that can interact
with α-chain epitopes in both pro-MSP and MSP. Uncleaved pro-
MSP appears as an 80 kDa band, whereas MSP is detected by its
reduced free 53 kDa α-chain. This assay was used to determine if pro-
MSP was proteolytically cleaved to mature MSP in wound fluids. A
representative result for drainage fluids obtained from two reduction
mammoplasty patients is shown in Fig 1. The western blot of the
blood plasmas of these two patients shows a pro-MSP band (lanes 4
and 7), without a detectable MSP band. In contrast, free MSP α-chain
is seen in the blots of wound drainage fluid (lanes 5, 6, and 8). An
estimate of the relative amounts of pro-MSP and MSP was made by
densitometry of the western blot bands. As shown in Table I for the
series of drain fluids collected 24 h post-surgery and for burn fluids
obtained within the first 24 h post-burn, MSP comprised about half
the total pro-MSP 1 MSP, in contrast to less than 10% for blood
plasma. Figure 2 shows that for three patients from whom multiple
samples were obtained, the relative amount of MSP diminished with
time after surgery, suggesting a decrease in conversion of pro-MSP to
MSP as postoperative inflammation subsided.
Pro-MSP convertase activity of wound fluid The detection of
MSP in wound fluid suggested the presence of a cell-bound or fluid
phase pro-MSP convertase in the wound bed. We therefore tested the
capacity of wound fluids from six patients (five reduction mammoplasty,
one burn) to cleave 125I-pro-MSP to MSP, and found pro-MSP
convertase activity in all. Representative radioautographs for three
different wound fluids after SDS-PAGE under reducing conditions
show MSP α- and β-chains, indicative of pro-MSP cleavage (Fig 3).
In contrast, three different normal human sera had no pro-MSP
convertase activity. Figure 4 illustrates the time course of 125I-pro-
MSP cleavage by two undiluted wound fluids containing µ3 nM pro-
MSP. The data indicate that there is sufficient enzymatic activity in
these fluids to generate detectable MSP within 10 min. The site of
pro-MSP cleavage is R483-V484 (Yoshimura et al, 1993), a typical scissile
bond for trypsin-like proteases. To obtain preliminary information about
the identity of the wound fluid pro-MSP convertase, we generated a
protease inhibitor profile, shown in Fig 5. Inhibition by aprotinin and
leupeptin is consistent with a trypsin-like serine protease (Barrett and
Salvesen, 1986). Among serum trypsin-like enzymes, purified kallikrein,
as well as coagulation factors XIa and XIIa, can cleave pro-MSP to
MSP (Wang et al, 1994b). Cleavage of pro-MSP by each of these
enzymes is inhibited by C1-inhibitor, and cleavage by serum kallikrein
is also inhibited by α2-macroglobulin (data not shown). Therefore, it
is unlikely that these enzymes account for the wound fluid activity,
which was not inhibited by α2-macroglobulin or C1-inhibitor (Fig 5,
lanes 8 and 9). Lack of inhibition by α1-antichymotrypsin rules
out chymotrypsin-like enzymes, and the EDTA result suggests that
metalloproteases do not have a predominant role.
Biologic activity of wound fluid MSP The concentration of MSP
in wound fluids (Table I) is in the range for optimal biologic activity
on target cells. We therefore determined if MSP in wound fluid is
biologically active, by adding the fluid to murine resident peritoneal
macrophages adherent to tissue culture wells. The wound fluid caused
the macrophages to put out cytoplasmic extensions, a shape change
characteristic of the action of MSP (Leonard and Skeel, 1976). To
determine if the effect of the wound fluid was due to MSP, we tested
for activity after passage of wound fluid down a column of immobilized
monoclonal antibody that binds MSP. Figure 6 shows that activity
was absorbed out by the anti-MSP column (Fig 6D), whereas wound
fluid effluent from the control column (Fig 6C) had an effect
comparable with that of the MSP positive control (Fig 6B). This result
shows that the macrophage shape change action of wound fluid was
mediated predominantly or exclusively by MSP.
RON expression in normal human skin Detectable immmuno-
reactivity for the RON receptor was not a prominent feature of normal
human skin (Tables II and III, Fig 7A). All cell layers comprising the
interfollicular epidermal surface were generally negative in either frozen
or paraffin sections (N 5 6); however, sections from two of six normal
subjects did show staining in epidermis and hair follicles; and, as noted
below, high RON expression was also observed in macrophages and
capillary endothelium in specimens from one of these two subjects.
The occasional detection of RON receptor protein in epidermal cells
of normal skin indicates that large differences in steady state expression
of RON may occur in the absence of observable pathology.
In the underlying normal human dermis, RON was not detected
in the endothelial cells lining veins or arteries in the three specimens
that contained these structures; however, RON was detected in the
capillary endothelium in sections from the same two subjects who
exhibited RON immunostaining in the epidermis (Table II). Immuno-
staining for RON was not observed in the major dermal cell population,
presumed to be fibroblasts.
RON immunoreactivity was noted in resident macrophages in
normal human dermis (Fig 7A). By quantitative morphometric analysis,
the incidence of RON positive resident macrophages was 3.4 macro-
phages per 100 µ2. To confirm that these cells were macrophages and
to determine if RON was expressed on all dermal macrophages, tissues
were evaluated by immunofluorescence double labeling with antibodies
to RON and to a macrophage-specific marker (see Materials and
Methods). In skin samples from six normal subjects, RON receptor
immunoreactivity appeared perfectly matched to cells identified as
macrophages (Fig 8A, B). Because no singly labeled cells were found,
the results show that all macrophages had detectable RON protein,
and all RON-positive cells scattered throughout the dermis are
macrophages.
RON receptor distribution in burn wounds
Epidermal resurfacing Re-epithelialization, one of the initial events
in wound repair, involves migration and proliferation of epidermal
keratinocytes. Because MSP has been shown to stimulate migration
and proliferation of murine keratinocyte cell lines, we expected that
RON, the receptor for this ligand, might be detected on the actively
healing epidermal elements within human burn wounds. Therefore
wounds from the acute burn period as well as later stages of repair
were evaluated for RON expression.
One of the first visible events of wound resurfacing is migration of
surviving keratinocytes. Surprisingly, migrating keratinocytes either at
the edges of the wounds (Fig 7D) or from surviving keratinocytes
within the deeply positioned sweat ducts (Fig 7C) or hair follicles
expressed little or no detectable RON receptor protein at any of the
time points examined (post-burn days 1–10). At wound edges and in
surviving epidermal islands, the proliferative population of keratinocytes
is immediately adjacent to the migratory population. In this proliferative
population, RON receptor protein was frequently not detectable in
the early burn wound period (Fig 7E); however, in the more established
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Figure 6. Murine resident peritoneal macrophage activation assay. Peritoneal cells were harvested from normal mice, and suspensions in DMEM were
added to tissue culture wells. After 30–45 min, DMEM was aspirated, and fluid samples to be assayed were added to the adherent cells. One hour later, cells were
washed with phosphate-buffered saline, stained with Diff-Quick, and photographed. (A) DMEM control; (B) 2 nM MSP; (C) wound fluid eluted from a control
mouse IgG column and diluted 1:30 in DMEM for assay; (D) wound fluid eluted from a monclonal anti-MSP immunoaffinity column and diluted 1:30 for assay.
Numbers of macrophages with lamellipodia (arrows) or elongated shapes: (A) 0; (B) 19; (C) 20; (D) 3.
Table II. Detection of RON receptor protein in normal skin
Epidermis Hair follicle Sweat gland
Sample Basal Spinous Granulosum Outer Inner Secretory Ductal Capillary
1pa – – – 1/– 1/– – 1 –
2p – – – – 1 3b 1 –
3p 1/– 111 111 1/– 11 3 – 111
4f – – – – – 3 3 –
5f 11 11 11 1 1 3 3 1
6f 1 – – 3 3 3 3 –
ap, paraffin sections; f, frozen sections.
b3, cell or structure was not present in the section; 1/–, patchy staining distribution.
Table III. Increased frequency of RON detection in burn
woundsa
Epidermisb Hair folliclec Capillaryd
Normal skin 2/6 4/6 2/6
Burn wound 14/14 12/12 7/16
aFrequencies derived from Tables II and IV.
bRON staining intensity of 11 or more in spinous keratinocytes in normal skin or in
burn wound hypertrophic epithelium
cRON staining of 11 or more in differentiated cells.
dRON staining of 11 or more in endothelial cells.
proliferative populations such as those comprising upwardly growing
sweat ducts (Fig 7C), or the multistratified epidermis in later phases
of resurfacing, or the hyperproliferative epidermis adjacent to the
wound bed (Fig 7F), prominent immunoreactivity for the RON
receptor was evident. Abundant RON protein was also frequently
apparent in the differentiated population of keratinocytes (Fig 7C–E).
A tabular summary of these data is shown to illustrate spatial distribution
of RON within each specimen in the series (Table IV).
Six burn wound specimens were re-examined for RON gene
expression, using in situ hybridization techniques. Figure 9(A–D)
illustrate that RON gene expression is more widespread than indicated
by the distribution of immunoreactive RON receptor protein. RON
receptor transcripts were prominent in advancing epithelial tips at the
wound edge (Fig 9A, B).
Granulation tissue formation (dermal repair) Immunoreactive RON
receptor protein was not detected in neutrophils, which accumulate
in early stages of burn wounds. As healing proceeds during days 2–5
after burn injury, tissue macrophages increasingly infiltrate into the
overlying eschar as well as granulation tissue within the wound bed.
RON receptor protein was readily apparent in these macrophages
within the overlying eschar (Fig 7G) and in focal regions of inflamma-
tion within deeper areas of the burn wound (Fig 8C). Double-labeling
with a macrophage marker confirmed the identity of these RON-
positive cells (Fig 8C, D). Nearly 100% of the cells that were identified
by the Am-3K macrophage marker appeared to be positive for the
RON receptor protein. By in situ hybridization, transcripts for the RON
receptor were prominently displayed on the infiltrating population of
macrophages (Fig 9A–D), thus confirming expression of the RON
receptor by macrophages within cutaneous sites of inflammation.
An unexpected finding of this study was the distribution of the
RON receptor protein on endothelial cells lining many but not all
capillaries in two of six sections of normal skin and eight of 16 sections
of burn wound skin (Tables II–IV, Fig 7H). The staining appeared
to be most prominent within areas of neovascularization but was by
no means a uniform finding. Expression of RON by endothelial cells
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Figure 7. Immunolocalization of the RON receptor using the ID-2 anti-serum. (A) Normal human skin shows no epidermal staining but RON protein
is present in some dermal cells, presumably macrophages. (B) In this newly resurfaced region of the epidermis that has not become fully stratified, RON receptor
protein is prominently displayed in the basal population but not in the suprabasal keratinocytes. (C) A surviving epithelial appendage growing toward the surface
at post-burn day 4. The migrating epidermal tip at the surface is unstained, but prominent immunoreactivity is present in the deeper (proliferative) keratinocytes
that are contributing cells upward to the surface layers. (D) At the epidermal edge (post-burn day 5), migrating cells (arrows) and the immediately adjacent
proliferating cells at the tip are unstained, but staining is observed in the more differentiated (upper) epidermal layers. (E) This noninjured hair follicle located
beneath the burned region shows RON receptor immunoreactivity only in the more differentiated cells of the inner root sheath. (F) This hyperproliferative
epidermis immediately adjacent to the burn shows strongest RON receptor staining in the proliferative layers but diminished staining in the differentiated layers
of outer stratum spinosum and granulosum layers. Staining is also present in capillaries in the papillary region of the dermis macrophages. (G) RON-positive cells
(presumably macrophages) in the exudate/eschar. (H) Staining for RON is present in capillary endothelium (arrows) and adjacent macrophages, but is absent in
fibroblasts. Scale bars: 25 µm.
lining capillaries was confirmed by detection of RON transcripts by
in situ hybridization (data not shown).
DISCUSSION
Members of the kringle protein family have in common the fact that
they are constitutively secreted as biologically inactive precursors,
which can be rapidly activated at the appropriate time and locus by
proteolytic cleavage. Pro-MSP is secreted by the liver (Bezerra et al,
1993; Yoshimura et al, 1993). Minimal or absent MSP in human serum
(Wang et al, 1994b) or plasma (Fig 1) indicates that pro-MSP is the
predominant form in circulating blood. We anticipated that if MSP
has a role in tissue injury, diffusion of pro-MSP from the circulating
blood into wound beds would result in proteolytic cleavage to active
MSP by a fluid phase or cell-associated pro-MSP convertase. Detection
of MSP by western blot in all tested exudates from both burn
wounds and surgical drains fulfilled this prediction. Furthermore, the
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Figure 9. Transcripts for the RON receptor at post-burn day 6 as
detected by in situ hybridization. (A, B) In these matching dark field and
bright field photomicrographs, silver grains [bright in (A), dark in (B)] are
concentrated over the migrating and proliferating epidermal sheet in the left
upper edge of the wound (arrows). In the right upper corner, no labeling is
present in the eschar covering the surface of the wound bed. Focal labeling
Figure 8. Immunofluorescence colocalization using ID-2 antibody to within inflammatory foci around dermal blood vessels is also present within the
the RON receptor (green) and AM-3K macrophage-specific antibody deeper areas of this wound (365). (C, D) In these matching dark and bright
(red). (A, B) Colabeling of a resident macrophage in normal (nonwounded) field photomicrographs, silver grains are clustered over the heavily vascularized
human dermis. (C, D) Colabeling of infiltrating macrophages in granulation areas within the wound bed. Labeling is highest over inflammatory cells
tissue at post-burn day 6. (macrophages) that immediately surround blood vessels (3110).
Table IV. Immunostaining for RON protein in tissues from 19 human burn wounds
Resurfacing epithelium Hypertrophic epithelium Hair follicle Sweat gland
PBDa Migr. Prolif. Diff. Basal Spinous Gran Outer Inner Secr. Ductal Cap. Mac.
1 3b 3 3 3 3 3 3 3 3 3 – –
1 3 – – 3 1 3 3 3 3 3 3 3
2 – – 11 1/–c 11 11 – 1 1 6 1 11/–
3 3 3 3 3 3 3 3 3 3 3 – –
4 – – 1 – 1 – 3 3 1 1 – 1
4 – 11/– 11/1 – 11 – 3 3 – 1 1 1
4 3 3 3 – 11 – 1/– 11 3 – 1 11
5 3 3 3 3 3 3 3 3 3 3 1 11
5 1/– 1/– 11 – 11 – – 11 3 1 – 11
5 – 3 3 3 1 1 3 3 3 3 3 3
5 – – 11 – 11 – – 11 3 3 3 3
5 1/– 1/– 11 1/– 11 1 – 11 3 1 1 1/–
6 3 3 3 3 3 3 1 1 3 3 – 1
6 3 3 3 3 3 3 – 1 1/– 1 – ?
6 – 1 11 1/– 11 11 1/– 11 3 1/– 11 11
7 – – 11 – 11 – – 11 3 1 – –
7 1/– – 11 – 11 – – 11 3 1 – 1
10 – – 11 – 11 111 – 111 3 1 11/– 11
11 3 1/– 11 1/– 111 – 1 11 3 3 – 111
aPBD, post-burn day.
b3, cell or structure was not present in the section.
c1/–, patchy staining.
concentration of MSP as determined by enzyme-linked immunosorbent
assay is in the optimal range for biologic activity.
In addition to immunochemical evidence for MSP in wound
exudates, we found that exudates induced morphologic changes in
adherent murine macrophages comparable with those induced by pure
recombinant MSP (Fig 6). The exudate activity was absorbed out
almost completely by an anti-MSP immunoaffinity column, but not
by a control column, indicating that the observed activity was accounted
for predominantly by MSP. Considering the host of mediators present
in wound exudates (Gailit and Clark, 1994), it is remarkable that MSP
appears to be almost exclusively responsible for induction of the
changes illustrated in Fig 6. Thus, in addition to our previous findings
that MSP induces phagocytosis via the CR3 receptor (Skeel et al,
1991), the time lapse study provides evidence for global membrane
activation.
RON expression is a relatively late event in mononuclear phagocyte
maturation, and also appears to be restricted to select phagocyte
populations: it is not present on human monocytes, and in mice it
occurs in resident peritoneal macrophages, but not in acute peritoneal
exudates or in splenic or alveolar lavage macrophages (Iwama et al,
1995). An important aspect of this work is the immunohistochemical
detection of the MSP receptor on all dermal macrophages of both
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normal skin and burn wound skin. This finding makes it reasonable
to extrapolate the in vitro data on murine macrophage pinocytosis and
phagocytosis to human dermal macrophages, and to suggest that
MSP may stimulate macrophage dependent wound debridement. The
importance of macrophages in wound debridement was first shown by
Leibovich and Ross in macrophage-depleted guinea pigs (Leibovich
and Ross, 1975). Electron micrographs of macrophages in wounds of
control animals showed cells filled with erythrocytes, neutrophils,
fibrin, and unidentifiable debris. In wounds of macrophage-depleted
animals, this debris was not ingested, and wound healing was delayed.
The concentration of mature MSP in extracellular fluid (ECF) will
depend on the rate of diffusion of pro-MSP from circulating blood
into tissues, the activity of ECF pro-MSP convertases, and degradation
of MSP in the ECF or after ligand-receptor cellular internalization.
We reported that murine peritoneal macrophages have a membrane-
bound pro-MSP convertase, and also an enzyme that cleaves and
inactivates pro-MSP (Wang et al, 1996b). A serum inhibitor, recently
identified as α1-antichymotrypsin (Skeel and Leonard, unpublished
data), blocks the inactivating enzyme. Thus a tissue macrophage target
cell might generate MSP when pro-MSP and α1-antichymotrypsin
diffuse into the tissue from the circulation. Additionally, we have now
shown that wound fluid exudates have pro-MSP convertase activity
(Figs 3, 4). The time course of pro-MSP cleavage by wound fluid
convertase (Fig 4) suggests that this enzymatic activity is sufficient to
account for the presence of mature MSP in wound fluids.
In addition to providing the first in vivo evidence of proteolytic
cleavage of pro-MSP to active MSP following tissue injury, our study
also shows that the RON receptor for MSP is highly upregulated
during the complex events that occur during human wound repair
(Table III). Numerous studies have shown upregulation of several
growth factors and their receptors in human or experimental animal
wounds (Antoniades et al, 1991, 1993; Wenczak et al, 1992; Danilenko
et al, 1995; Takenaka et al, 1997). Our methods for detection of MSP
receptor message or protein are similar, but differ with respect to the
MSP ligand, which is generated in injured tissue by cleavage of pre-
formed pro-MSP. In contrast, published studies focus on de novo
synthesis of growth factor ligands by cells in the damaged locus. It
would be of interest to identify the putative mediators in the wound
environment that stimulate synthesis of these growth factors and
upregulation of their receptors.
Table IV shows that upregulation of RON expression by epithelial
cells in human burn wounds occurs in proliferating or differentiated
populations or both. It is possible that MSP could promote proliferation
in some keratinocytes and differentitation in others. There is abundant
evidence in the literature that effects of ligand binding to receptor
tyrosine kinases can be determined by the type and state of the target
cell (Schlessinger and Ullrich, 1992). For example, occupancy by NGF
of the trk receptor tyrosine kinase caused differentiation of neurons,
but proliferation of trk-transfected fibroblasts (Glass et al, 1991). In cell
lines transfected with STK, the murine receptor for MSP, addition of
the ligand caused proliferation of the pro-B cell line, but apoptotic
death of the mouse erythroleukemia (MEL) cell line Iwama et al
(1996). Although an identical group of signal transduction proteins
became associated with the STK multifunctional docking site in both
transfectants, two interacting phosphorylated proteins were found only
in the MEL line. Thus, the functional result of receptor occupancy
appears to depend on the state and availability of a broad spectrum of
transducing proteins. In the case of the MSP receptor, already docu-
mented outcomes include proliferation, apoptosis, stimulation of mem-
brane and cytoplasmic motility, and activation of integrin receptors
that result in increased adherence to substrate (Danilkovitch and
Leonard, unpublished data) or phagocytosis. Alternatively, the promin-
ence of RON receptor transcripts in advancing epithelial tips and the
paucity of RON protein in these same cell populations may relate
more to RON receptor production and turnover. Wounded epidermis
at tips may be high turnover, but the equilibrium may be tipped in
favor of RON accumulation in the more differentiated stable cell
populations.
In conclusion, this study provides the first in vivo evidence for a role
for MSP in tissue injury: upregulation of the RON receptor on
keratinocytes, as well as the presence of pro-MSP convertase activity
and mature MSP in wound exudates. Because not all mononuclear
phagocyte populations express the receptor for MSP (Iwama et al,
1995), it was also important to find that dermal macrophages express
RON, which makes it likely that mature MSP can stimulate wound
debridement by these cells. Another novel finding of this study was
the expression of RON message and protein on capillary endothelial
cells. Perhaps the presence of yet another receptor protein tyrosine
kinase on capillary endothelial cells might have been anticipated. These
cells, with their assortment of tyrosine kinase receptors, are targets for
various ligands that are thought to mediate proliferation and migration
of new capillaries, the hallmark of granulation tissue. Experiments to
determine if MSP is angiogenic are in progress.
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